Microglia activation: a role for mitochondrial DNA?

Marcello Pinti,Diana Ferraro,Milena Nasi

DOI: https://doi.org/10.4103/1673-5374.313034

2021-01-01

Neural Regeneration Research

Abstract:Marcello Pinti, Diana Ferraro, Milena Nasi Neural Regeneration Research 2021 16(12):2393-2394

neurosciences,cell biology

What problem does this paper attempt to address?

Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia

Milena Nasi,Anna De Gaetano,Elena Bianchini,Sara De Biasi,Lara Gibellini,Anita Neroni,Marco Mattioli,Marcello Pinti,Domenico Lo Tartaro,Rebecca Borella,Anna Vittoria Mattioli,Johanna Chester,Alessandra Melegari,Anna Maria Simone,Diana Ferraro,Francesca Vitetta,Patrizia Sola,Andrea Cossarizza

DOI: https://doi.org/10.1016/j.mcn.2020.103538

Abstract:Microglia are the resident innate immune cells of the central nervous system and exert functions of host defense and maintenance of normal tissue homeostasis, along with support of neuronal processes in the healthy brain. Chronic and dysregulated microglial cell activation has increasingly been linked to the status of neuroinflammation underlying many neurodegenerative diseases, including multiple sclerosis (MS). However, the stimulus (or stimuli) and mechanisms by which microglial activation is initiated and maintained MS are still debated. The purpose of our research was to investigate whether the endogenous mitochondrial (mt)-derived damage-associated molecular patterns (MTDs) mtDNA, N-formyl peptides and cardiolipin (CL) contribute to these phenomena. We characterized the effects of the abovementioned MTDs on microglia activation in vitro (i.e. using HMC3 cells) by evaluating the expression of gene coding for proteins involved in their binding and coupled to downstream signaling pathways, the up-regulation of markers of activation on the cell surface and the production of pro-inflammatory cytokines and reactive oxygen species. At the transcriptional level, significant variations in the mRNA relative expression of five of eleven selected genes were observed in response to stimulation. No changes in activation of antigenic profile or functional properties of HMC3 cells were observed; there was no up-regulation of HLA-DR expression or increased secretion of tumor necrosis factor-α and interleukin-6. However, after stimulation with mtDNA and CL, an increase in cellular oxidative stress, but not in the mt ROS O2-, compared to control cells, were observed. There were no effects on cell viability. Overall, our data suggest that MTDs could cause a failure in microglial activation toward a pro-inflammatory phenotype, possibly triggering an endogenous regulatory mechanism for the resolution of neuroinflammation. This could open a door for the development of drugs selectively targeting microglia and modulating its functionality to treat MS and/or other neurodegenerative conditions in which MTDs have a pathogenic relevance.
Activation of Microglia Depends on Na+/H+Exchange-Mediated H+Homeostasis

Yan Liu,Douglas B. Kintner,Vishal Chanana,Jehad Algharabli,Xinzhi Chen,Yanqin Gao,Jun Chen,Peter Ferrazzano,Julie K. Olson,Dandan Sun

DOI: https://doi.org/10.1523/jneurosci.3950-10.2010

2010-01-01

Journal of Neuroscience

Abstract:H+extrusion is important for sustained NADPH oxidase activation after “respiratory” burst in macrophage/microglia activation. In this study, we investigated the role of Na+/H+exchanger isoform 1 (NHE-1) in activation of microglia after lipopolysaccharide (LPS) or oxygen and glucose deprivation and reoxygenation (OGD/REOX) exposure. NHE-1 functioned in maintaining basal pHiof immortalized M4T.4 microglia or mouse primary microglia. Pharmacological inhibition of NHE-1 activity with the potent inhibitor cariporide [HOE 642 (4-isopropyl-3-methylsulfonyl-benzoyl-guanidine-methanesulfonate)] abolished pHiregulation in microglia under basal conditions. Activation of microglia either by LPS, phorbol myristate acetate, or OGD/REOX accelerated pHiregulation and caused pHielevation, which was accompanied with an increase in [Na+]iand [Ca2+]ias well as production of superoxide anion and cytokines. Interestingly, inhibition of NHE-1 not only abolished pHiregulation but also reduced production of superoxide anion as well as expression of cytokines and inducible nitric oxide synthase. Together, these results reveal that there was a concurrent activation of NHE-1 in microglia in response to proinflammatory stimuli. The study suggests that NHE-1 functions to maintain microglial pHihomeostasis allowing for sustained NADPH oxidase function and “respiratory” burst.
Microglial Activation Induced by Neurodegeneration

Yong Zhou,Yan Wang,Monika Kovacs,Jinghua Jin,Jing Zhang

DOI: https://doi.org/10.1074/mcp.M500114-MCP200

IF: 7.381

2005-01-01

Molecular & Cellular Proteomics

Abstract:Neuroinflammation mediated by microglial activation appears to play an essential role in the pathogenesis of Parkinson disease; however, the mechanisms by which microglia are activated are not fully understood. Thus, we first evaluated the effects of two parkinsonian toxicants, manganese ethylene bisdithiocarbamate (Mn-EBDC) and 1-methyl-4-phenylpyridine (MPP+), on microglial activation as well as associated dopaminergic (DAergic) neurotoxicity in primary cell culture systems. The results demonstrated that, when rat primary mesencephalic neuron-enriched or neuron-microglia mixed cultures were treated with Mn-EBDC at 2 - 8 mu M or MPP+ at 0.25 - 5 mu M, respectively, for 7 days, both toxicants were capable of inducing DAergic neurodegeneration as well as activating microglia via a mechanism secondary to DAergic neurodegeneration. Furthermore activated microglia subsequently enhanced DAergic neurotoxicity induced by Mn- EBDC or MPP+. Detailed scrutiny of neuron-microglia interactions identified a fraction of the conditioned media derived from a DAergic cell line treated with Mn- EBDC or MPP+ that potently activated microglia. To further define potential mediators leading to microglial activation secondary to neurodegeneration, we utilized a quantitative proteomic technique termed SILAC ( for stable isotope labeling by amino acids in cell culture) to compare the protein profiles of MPP+-treated cellular fraction that mediated microglial activation as compared with controls. The search revealed numerous novel proteins that are potentially important in neurodegeneration-mediated microglial activation, a process believed to be critical in Parkinson disease progression.
Hidden role of microglia during neurodegenerative disorders and neurocritical care: A mitochondrial perspective

Xinrun Wang,Jiyun Hu,Shucai Xie,Wenchao Li,Haisong Zhang,Li Huang,Zhaoxin Qian,Chunguang Zhao,Lina Zhang

DOI: https://doi.org/10.1016/j.intimp.2024.113024

2024-08-31

Abstract:The incidence of aging-related neurodegenerative disorders and neurocritical care diseases is increasing worldwide. Microglia, the main inflammatory cells in the brain, could be potential viable therapeutic targets for treating neurological diseases. Interestingly, mitochondrial functions, including energy metabolism, mitophagy and transfer, fission and fusion, and mitochondrial DNA expression, also change in activated microglia. Notably, mitochondria play an active and important role in the pathophysiology of neurodegenerative disorders and neurocritical care diseases. This review briefly summarizes the current knowledge on mitochondrial dysfunction in microglia in neurodegenerative disorders and neurocritical care diseases and comprehensively discusses the prospects of the application of neurological injury prevention and treatment targets by mitochondria.
Mitochondrial complex I activity in microglia sustains neuroinflammation

L. Peruzzotti-Jametti,C. M. Willis,G. Krzak,R. Hamel,L. Pirvan,R.-B. Ionescu,J. A. Reisz,H. A. Prag,M. E. Garcia-Segura,V. Wu,Y. Xiang,B. Barlas,A. M. Casey,A. M. R. van den Bosch,A. M. Nicaise,L. Roth,G. R. Bates,H. Huang,P. Prasad,A. E. Vincent,C. Frezza,C. Viscomi,G. Balmus,Z. Takats,J. C. Marioni,A. D’Alessandro,M. P. Murphy,I. Mohorianu,S. Pluchino

DOI: https://doi.org/10.1038/s41586-024-07167-9

IF: 64.8

2024-03-14

Nature

Abstract:Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis 1 . Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells 2 . However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Ccomplex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system 3 .

multidisciplinary sciences
Role of Mitochondrial Dynamics in Microglial Activation and Metabolic Switch

Alejandro Montilla,Asier Ruiz,Mar Marquez,Amanda Sierra,Carlos Matute,Maria Domercq

DOI: https://doi.org/10.4049/immunohorizons.2100068

2021-08-10

ImmunoHorizons

Abstract:Microglia act as sensors of injury in the brain, favoring its homeostasis. Their activation and polarization toward a proinflammatory phenotype are associated with injury and disease. These processes are linked to a metabolic reprogramming of the cells, characterized by high rates of glycolysis and suppressed oxidative phosphorylation. This metabolic switch can be reproduced in vitro by microglial stimulation with LPS plus IFN-γ. To understand the mechanisms regulating mitochondrial respiration abolishment, we examined potential alterations in mitochondrial features during this switch using rat primary microglia. Cells did not show any change in mitochondrial membrane potential, suggesting a limited impact in the mitochondrial viability. We provide evidence that reverse operation of F0F1-ATP synthase contributes to mitochondrial membrane potential. In addition, we studied the possible implication of mitochondrial dynamics in the metabolic switch using the mitochondrial division inhibitor-1 (Mdivi-1), which blocks dynamin-related protein 1 (Drp1)-dependent mitochondrial fission. Mdivi-1 significantly reduced the expression of proinflammatory markers in LPS plus IFN-γ-treated microglia. However, this inhibition did not lead to a recovery of the oxidative phosphorylation ablation by LPS plus IFN-γ or to a microglia repolarization. Altogether, these results suggest that Drp1-dependent mitochondrial fission, although potentially involved in microglial activation, does not play an essential role in metabolic reprogramming and repolarization of microglia.
Mitochondrial DNA Leakage and cGas/STING Pathway in Microglia: Crosstalk Between Neuroinflammation and Neurodegeneration

Yuqian Liu,Bohan Zhang,Ruonan Duan,Yiming Liu

DOI: https://doi.org/10.1016/j.neuroscience.2024.04.009

IF: 3.708

2024-04-29

Neuroscience

Abstract:Neurodegenerative diseases, characterized by abnormal deposition of misfolded proteins, often present with progressive loss of neurons. Chronic neuroinflammation is a striking hallmark of neurodegeneration. Microglia, as the primary immune cells in the brain, is the main type of cells that participate in the formation of inflammatory microenvironment. Cytoplasmic free mitochondrial DNA (mtDNA), a common component of damage-associated molecular patterns (DAMPs), can activate the cGas/stimulator of interferon genes (STING) signalling, which subsequently produces type I interferon and proinflammatory cytokines. There are various sources of free mtDNA in microglial cytoplasm, but mitochondrial oxidative stress accumulation plays the vital role. The upregulation of cGas/STING pathway in microglia contributes to the abnormal and persistent microglial activation, accompanied by excessive secretion of neurotoxic inflammatory mediators such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), which exacerbates the damage of neurons and promotes the development of neurodegeneration. Currently, novel therapeutic approaches need to be found to delay the progression of neurodegenerative disorders, and regulation of the cGas/STING signaling in microglia may be a potential target.

neurosciences
Polymorphic regulation of mitochondrial fission and fusion modifies phenotypes of microglia in neuroinflammation

Mitsuhiko Katoh,Bao Wu,Huy Bang Nguyen,Truc Quynh Thai,Ryo Yamasaki,Haiyan Lu,Anna M. Rietsch,Musab M. Zorlu,Youichi Shinozaki,Yurika Saitoh,Sei Saitoh,Takashi Sakoh,Kazuhiro Ikenaka,Schuichi Koizumi,Richard M. Ransohoff,Nobuhiko Ohno

DOI: https://doi.org/10.1038/s41598-017-05232-0

IF: 4.6

2017-07-10

Scientific Reports

Abstract:Microglia are the resident macrophages of the central nervous system and play complex roles in the milieu of diseases including the primary diseases of myelin. Although mitochondria are critical for cellular functions and survival in the nervous system, alterations in and the roles of mitochondrial dynamics and associated signaling in microglia are still poorly understood. In the present study, by combining immunohistochemistry and 3D ultrastructural analyses, we show that mitochondrial fission/fusion in reactive microglia is differentially regulated from that in monocyte-derived macrophages and the ramified microglia of normal white matter in myelin disease models. Mouse cerebral microglia in vitro demonstrated that stimulation of TLR4 with lipopolysaccharide, widely used to examine microglial reactions, caused the activation of the mitochondrial fission protein, dynamin-related protein 1 (Drp1) and enhanced production of reactive oxygen species (ROS). The increase in the ROS level activated 5′ adenosine monophosphate-activated protein kinase (AMPK), and facilitated elongation of mitochondria along the microtubule tracks. These results suggest that the polymorphic regulation of mitochondrial fission and fusion in reactive microglia is mediated by distinct signaling under inflammatory conditions, and modulates microglial phenotypes through the production of ROS.

multidisciplinary sciences
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease

Yun Li,Xiaohuan Xia,Yi Wang,Jialin C. Zheng

DOI: https://doi.org/10.1186/s12974-022-02613-9

IF: 9.3

2022-10-07

Journal of Neuroinflammation

Abstract:Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly globally. Emerging evidence has demonstrated microglia-driven neuroinflammation as a key contributor to the onset and progression of AD, however, the mechanisms that mediate neuroinflammation remain largely unknown. Recent studies have suggested mitochondrial dysfunction including mitochondrial DNA (mtDNA) damage, metabolic defects, and quality control (QC) disorders precedes microglial activation and subsequent neuroinflammation. Therefore, an in-depth understanding of the relationship between mitochondrial dysfunction and microglial activation in AD is important to unveil the pathogenesis of AD and develop effective approaches for early AD diagnosis and treatment. In this review, we summarized current progress in the roles of mtDNA, mitochondrial metabolism, mitochondrial QC changes in microglial activation in AD, and provide comprehensive thoughts for targeting microglial mitochondria as potential therapeutic strategies of AD.

immunology,neurosciences
Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases

Miao-miao Lin,Na Liu,Zheng-hong Qin,Yan Wang

DOI: https://doi.org/10.1038/s41401-022-00879-6

IF: 7.169

2022-03-01

Acta Pharmacologica Sinica

Abstract:Abstract Both mitochondrial dysfunction and neuroinflammation are implicated in neurodegeneration and neurodegenerative diseases. Accumulating evidence shows multiple links between mitochondrial dysfunction and neuroinflammation. Mitochondrial-derived damage-associated molecular patterns (DAMPs) are recognized by immune receptors of microglia and aggravate neuroinflammation. On the other hand, inflammatory factors released by activated glial cells trigger an intracellular cascade, which regulates mitochondrial metabolism and function. The crosstalk between mitochondrial dysfunction and neuroinflammatory activation is a complex and dynamic process. There is strong evidence that mitochondrial dysfunction precedes neuroinflammation during the progression of diseases. Thus, an in-depth understanding of the specific molecular mechanisms associated with mitochondrial dysfunction and the progression of neuroinflammation in neurodegenerative diseases may contribute to the identification of new targets for the treatment of diseases. In this review, we describe in detail the DAMPs that induce or aggravate neuroinflammation in neurodegenerative diseases including mtDNA, mitochondrial unfolded protein response (mtUPR), mitochondrial reactive oxygen species (mtROS), adenosine triphosphate (ATP), transcription factor A mitochondria (TFAM), cardiolipin, cytochrome c , mitochondrial Ca 2+ and iron.

pharmacology & pharmacy,chemistry, multidisciplinary
Microglial mitochondrial DNA release contributes to neuroinflammation after intracerebral hemorrhage through activating AIM2 inflammasome

Feng Gu,Zongqi Wang,Haojie Ding,Xinyu Tao,Juyi Zhang,Kun Dai,Xiang Li,Haitao Shen,Haiying Li,Zhouqing Chen,Zhong Wang

DOI: https://doi.org/10.1016/j.expneurol.2024.114950

Abstract:Intracerebral hemorrhage (ICH) is a severe disease that often leads to disability and death. Neuroinflammatory response is a key causative factor of early secondary brain injury after ICH. AIM2 is a DNA-sensing protein that recognizes cytosolic double-stranded DNA and take a significant part in neuroinflammation. Mitochondrial DNA participates in the translation of proteins such as the respiratory chain in the mitochondria. Whether mtDNA is involved in forming AIM2 inflammasome after ICH remains unclear. We used mice to construct ICH model in vivo and we used BV2 microglial cells treated with oxyhemoglobin to simulate ICH in vitro. Following lentiviral transfection to overexpress AIM2 antagonist P202, a notable decrease was observed in the levels of AIM2 inflammasome-associated proteins, leading to a reduction in dead neurons surrounding the hematoma and an enhancement in long-term and short-term behavior of neurological deficits. We further explored whether mtDNA took part in the AIM2 activation after ICH. The cytosolic mtDNA level was down-regulated by the mitochondrial division protector Mdivi-1 and up-regulated by transfection of mtDNA into cytoplasm. We found the expression level of AIM2 inflammasome-related proteins and inflammatory cytokines release were regulated by the cytosolic mtDNA level. In conclusion, after ICH, the mtDNA content in the cytoplasm of microglia around the hematoma rises, causing AIM2 inflammation leading to neuronal apoptosis, which leads to neurological deficits in mice. On the other hand, P202 was able to block inflammatory vesicle activation and improve neurological function by preventing the interaction between AIM2 protein and mitochondrial DNA.
Mitochondria in Neurogenesis: Implications for Mitochondrial Diseases

Dario Brunetti,Werner Dykstra,Stephanie Le,Annika Zink,Alessandro Prigione

DOI: https://doi.org/10.1002/stem.3425

IF: 5.845

2021-06-05

Stem Cells

Abstract:Abstract Mitochondria are organelles with recognized key roles in cellular homeostasis, including bioenergetics, redox, calcium signaling, and cell death. Mitochondria are essential for neuronal function, given the high energy demands of the human brain. Consequently, mitochondrial diseases affecting oxidative phosphorylation (OXPHOS) commonly exhibit neurological impairment. Emerging evidence suggests that mitochondria are important not only for mature postmitotic neurons but also for the regulation of neural progenitor cells (NPCs) during the process of neurogenesis. These recent findings put mitochondria as central regulator of cell fate decisions during brain development. OXPHOS mutations may disrupt the function of NPCs and thereby impair the metabolic programming required for neural fate commitment. Promoting the mitochondrial function of NPCs could therefore represent a novel interventional approach against incurable mitochondrial diseases.

oncology,cell biology,hematology,biotechnology & applied microbiology,cell & tissue engineering
Cytoplasmic Escape of Mitochondrial DNA Mediated by Mfn2 Downregulation Promotes Microglial Activation Via Cgas‐sting Axis in Spinal Cord Injury (adv. Sci. 4/2024)

Fei-Long Wei,Tian-Fu Wang,Chao-Li Wang,Zhen-Peng Zhang,Jing-Wei Zhao,Wei Heng,Zhen Tang,Ming-Rui Du,Xiao-Dong Yan,Xiao-Xiang Li,Zheng Guo,Ji-Xian Qian,Cheng-Pei Zhou

DOI: https://doi.org/10.1002/advs.202470021

IF: 15.1

2024-01-01

Advanced Science

Abstract:Advanced ScienceVolume 11, Issue 4 2470021 Cover PictureOpen Access Cytoplasmic Escape of Mitochondrial DNA Mediated by Mfn2 Downregulation Promotes Microglial Activation via cGas-Sting Axis in Spinal Cord Injury (Adv. Sci. 4/2024) Fei-Long Wei, Fei-Long WeiSearch for more papers by this authorTian-Fu Wang, Tian-Fu WangSearch for more papers by this authorChao-Li Wang, Chao-Li WangSearch for more papers by this authorZhen-Peng Zhang, Zhen-Peng ZhangSearch for more papers by this authorJing-Wei Zhao, Jing-Wei ZhaoSearch for more papers by this authorWei Heng, Wei HengSearch for more papers by this authorZhen Tang, Zhen TangSearch for more papers by this authorMing-Rui Du, Ming-Rui DuSearch for more papers by this authorXiao-Dong Yan, Xiao-Dong YanSearch for more papers by this authorXiao-Xiang Li, Xiao-Xiang LiSearch for more papers by this authorZheng Guo, Zheng GuoSearch for more papers by this authorJi-Xian Qian, Ji-Xian QianSearch for more papers by this authorCheng-Pei Zhou, Cheng-Pei ZhouSearch for more papers by this author Fei-Long Wei, Fei-Long WeiSearch for more papers by this authorTian-Fu Wang, Tian-Fu WangSearch for more papers by this authorChao-Li Wang, Chao-Li WangSearch for more papers by this authorZhen-Peng Zhang, Zhen-Peng ZhangSearch for more papers by this authorJing-Wei Zhao, Jing-Wei ZhaoSearch for more papers by this authorWei Heng, Wei HengSearch for more papers by this authorZhen Tang, Zhen TangSearch for more papers by this authorMing-Rui Du, Ming-Rui DuSearch for more papers by this authorXiao-Dong Yan, Xiao-Dong YanSearch for more papers by this authorXiao-Xiang Li, Xiao-Xiang LiSearch for more papers by this authorZheng Guo, Zheng GuoSearch for more papers by this authorJi-Xian Qian, Ji-Xian QianSearch for more papers by this authorCheng-Pei Zhou, Cheng-Pei ZhouSearch for more papers by this author First published: 26 January 2024 https://doi.org/10.1002/advs.202470021AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Graphical Abstract Spinal Cord Injury After spinal cord injury, the mitochondrial DNA of microglia escapes into the cytoplasm, thereby triggering the activation of the cGas-Sting pathway, which in turn initiates the activation of pro-inflammatory signals and the subsequent release of inflammatory factors, ultimately leading to neuronal cell death. More details can be found in article number 2305442 by Zheng Guo, Ji-Xian Qian, Cheng-Pei Zhou, and co-workers. Volume11, Issue4January 26, 20242470021 RelatedInformation
Mitochondrial reverse electron transport in myeloid cells perpetuates neuroinflammation

L. Peruzzotti-Jametti,C.M. Willis,R. Hamel,G. Krzak,J.A. Reisz,H.A. Prag,V. Wu,Y. Xiang,A.M.R. van den Bosch,A.M. Nicaise,L. Roth,G.R. Bates,H. Huang,A.E. Vincent,C. Frezza,C. Viscomi,J.C. Marioni,A. D’Alessandro,Z. Takats,M.P. Murphy,S. Pluchino

DOI: https://doi.org/10.1101/2024.01.03.574059

2024-01-04

Abstract:Sustained smouldering, or low grade, activation of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis (MS) . Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells . However, how these metabolic features act to perpetuate neuroinflammation is currently unknown. Using a multiomics approach, we identified a new molecular signature that perpetuates the activation of myeloid cells through mitochondrial complex II (CII) and I (CI) activity driving reverse electron transport (RET) and the production of reactive oxygen species (ROS). Blocking RET in pro-inflammatory myeloid cells protected the central nervous system (CNS) against neurotoxic damage and improved functional outcomes in animal disease models . Our data show that RET in myeloid cells is a potential new therapeutic target to foster neuroprotection in smouldering inflammatory CNS disorders .

Neuroscience
Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration

Anna Picca,Riccardo Calvani,Hélio José Coelho-Junior,Francesco Landi,Roberto Bernabei,Emanuele Marzetti

DOI: https://doi.org/10.3390/antiox9080647

IF: 7.675

2020-07-22

Antioxidants

Abstract:Oxidative stress develops as a response to injury and reflects a breach in the cell’s antioxidant capacity. Therefore, the fine-tuning of reactive oxygen species (ROS) generation is crucial for preserving cell’s homeostasis. Mitochondria are a major source and an immediate target of ROS. Under different stimuli, including oxidative stress and impaired quality control, mitochondrial constituents (e.g., mitochondrial DNA, mtDNA) are displaced toward intra- or extracellular compartments. However, the mechanisms responsible for mtDNA unloading remain largely unclear. While shuttling freely within the cell, mtDNA can be delivered into the extracellular compartment via either extrusion of entire nucleoids or the generation and release of extracellular vesicles. Once discarded, mtDNA may act as a damage-associated molecular pattern (DAMP) and trigger an innate immune inflammatory response by binding to danger-signal receptors. Neuroinflammation is associated with a large array of neurological disorders for which mitochondrial DAMPs could represent a common thread supporting disease progression. The exploration of non-canonical pathways involved in mitochondrial quality control and neurodegeneration may unveil novel targets for the development of therapeutic agents. Here, we discuss these processes in the setting of two common neurodegenerative diseases (Alzheimer’s and Parkinson’s disease) and Down syndrome, the most frequent progeroid syndrome.

biochemistry & molecular biology,chemistry, medicinal,food science & technology
Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy

Luca Muzio,Alice Viotti,Gianvito Martino

DOI: https://doi.org/10.3389/fnins.2021.742065

IF: 4.3

2021-09-24

Frontiers in Neuroscience

Abstract:Microglia are the resident macrophages of the central nervous system (CNS) acting as the first line of defense in the brain by phagocytosing harmful pathogens and cellular debris. Microglia emerge from early erythromyeloid progenitors of the yolk sac and enter the developing brain before the establishment of a fully mature blood–brain barrier. In physiological conditions, during brain development, microglia contribute to CNS homeostasis by supporting cell proliferation of neural precursors. In post-natal life, such cells contribute to preserving the integrity of neuronal circuits by sculpting synapses. After a CNS injury, microglia change their morphology and down-regulate those genes supporting homeostatic functions. However, it is still unclear whether such changes are accompanied by molecular and functional modifications that might contribute to the pathological process. While comprehensive transcriptome analyses at the single-cell level have identified specific gene perturbations occurring in the “pathological” microglia, still the precise protective/detrimental role of microglia in neurological disorders is far from being fully elucidated. In this review, the results so far obtained regarding the role of microglia in neurodegenerative disorders will be discussed. There is solid and sound evidence suggesting that regulating microglia functions during disease pathology might represent a strategy to develop future therapies aimed at counteracting brain degeneration in multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis.

neurosciences
Miro1 Enhances Mitochondria Transfer from Multipotent Mesenchymal Stem Cells (MMSC) to Neural Cells and Improves the Efficacy of Cell Recovery

Valentina A. Babenko,Denis N. Silachev,Vasily A. Popkov,Ljubava D. Zorova,Irina B. Pevzner,Egor Y. Plotnikov,Gennady T. Sukhikh,Dmitry B. Zorov,Valentina Babenko,Denis Silachev,Vasily Popkov,Ljubava Zorova,Irina Pevzner,Egor Plotnikov,Gennady Sukhikh,Dmitry Zorov

DOI: https://doi.org/10.3390/molecules23030687

IF: 4.6

2018-03-19

Molecules

Abstract:A recently discovered key role of reactive oxygen species (ROS) in mitochondrial traffic has opened a wide alley for studying the interactions between cells, including stem cells. Since its discovery in 2006, intercellular mitochondria transport has been intensively studied in different cellular models as a basis for cell therapy, since the potential of replacing malfunctioning organelles appears to be very promising. In this study, we explored the transfer of mitochondria from multipotent mesenchymal stem cells (MMSC) to neural cells and analyzed its efficacy under normal conditions and upon induction of mitochondrial damage. We found that mitochondria were transferred from the MMSC to astrocytes in a more efficient manner when the astrocytes were exposed to ischemic damage associated with elevated ROS levels. Such transport of mitochondria restored the bioenergetics of the recipient cells and stimulated their proliferation. The introduction of MMSC with overexpressed Miro1 in animals that had undergone an experimental stroke led to significantly improved recovery of neurological functions. Our data suggest that mitochondrial impairment in differentiated cells can be compensated by receiving healthy mitochondria from MMSC. We demonstrate a key role of Miro1, which promotes the mitochondrial transfer from MMSC and suggest that the genetic modification of stem cells can improve the therapies for the injured brain.

chemistry, multidisciplinary,biochemistry & molecular biology
Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s disease

Souvarish Sarkar,Emir Malovic,Dilshan S. Harishchandra,Shivani Ghaisas,Nikhil Panicker,Adhithiya Charli,Bharathi N. Palanisamy,Dharmin Rokad,Huajun Jin,Vellareddy Anantharam,Arthi Kanthasamy,Anumantha G. Kanthasamy

DOI: https://doi.org/10.1038/s41531-017-0032-2

2017-10-17

Abstract:The NLRP3 inflammasome signaling pathway is a major contributor to the neuroinflammatory process in the central nervous system. Oxidative stress and mitochondrial dysfunction are key pathophysiological processes of many chronic neurodegenerative diseases, including Parkinson’s disease (PD). However, the inter-relationship between mitochondrial defects and neuroinflammation is not well understood. In the present study, we show that impaired mitochondrial function can augment the NLRP3 inflammasome-driven proinflammatory cascade in microglia. Primary mouse microglia treated with the common inflammogen LPS increased NLRP3 and pro-IL-1β expression. Interestingly, exposure of LPS-primed microglial cells to the mitochondrial complex-I inhibitory pesticides rotenone and tebufenpyrad specifically potentiated the NLRP3 induction, ASC speck formation and pro-IL-1β processing to IL-1β in a dose-dependent manner, indicating that mitochondrial impairment heightened the NLRP3 inflammasome-mediated proinflammatory response in microglia. The neurotoxic pesticide-induced NLRP3 inflammasome activation was accompanied by bioenergetic defects and lysosomal dysfunction in microglia. Furthermore, the pesticides enhanced mitochondrial ROS generation in primary microglia, while amelioration of mitochondria-derived ROS by the mitochondria-targeted antioxidant mito-apocynin completely abolished IL-1β release, indicating mitochondrial ROS drives potentiation of the NLRP3 inflammasome in microglia. Exposure to conditioned media obtained from mitochondrial inhibitor-treated, LPS-primed microglial cells, but not unprimed cells, induced dopaminergic neurodegeneration in cultured primary mesencephalic and human dopaminergic neuronal cells (LUHMES). Notably, our in vivo results with chronic rotenone rodent models of PD further support the activation of proinflammatory NLRP3 inflammasome signaling due to mitochondrial dysfunction. Collectively, our results demonstrate that mitochondrial impairment in microglia can amplify NLRP3 inflammasome signaling, which augments the dopaminergic neurodegenerative process.
Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease

Souvarish Sarkar,Emir Malovic,Dilshan S Harishchandra,Shivani Ghaisas,Nikhil Panicker,Adhithiya Charli,Bharathi N Palanisamy,Dharmin Rokad,Huajun Jin,Vellareddy Anantharam,Arthi Kanthasamy,Anumantha G Kanthasamy

DOI: https://doi.org/10.1038/s41531-017-0032-2

2017-10-17

Abstract:The NLRP3 inflammasome signaling pathway is a major contributor to the neuroinflammatory process in the central nervous system. Oxidative stress and mitochondrial dysfunction are key pathophysiological processes of many chronic neurodegenerative diseases, including Parkinson's disease (PD). However, the inter-relationship between mitochondrial defects and neuroinflammation is not well understood. In the present study, we show that impaired mitochondrial function can augment the NLRP3 inflammasome-driven proinflammatory cascade in microglia. Primary mouse microglia treated with the common inflammogen LPS increased NLRP3 and pro-IL-1β expression. Interestingly, exposure of LPS-primed microglial cells to the mitochondrial complex-I inhibitory pesticides rotenone and tebufenpyrad specifically potentiated the NLRP3 induction, ASC speck formation and pro-IL-1β processing to IL-1β in a dose-dependent manner, indicating that mitochondrial impairment heightened the NLRP3 inflammasome-mediated proinflammatory response in microglia. The neurotoxic pesticide-induced NLRP3 inflammasome activation was accompanied by bioenergetic defects and lysosomal dysfunction in microglia. Furthermore, the pesticides enhanced mitochondrial ROS generation in primary microglia, while amelioration of mitochondria-derived ROS by the mitochondria-targeted antioxidant mito-apocynin completely abolished IL-1β release, indicating mitochondrial ROS drives potentiation of the NLRP3 inflammasome in microglia. Exposure to conditioned media obtained from mitochondrial inhibitor-treated, LPS-primed microglial cells, but not unprimed cells, induced dopaminergic neurodegeneration in cultured primary mesencephalic and human dopaminergic neuronal cells (LUHMES). Notably, our in vivo results with chronic rotenone rodent models of PD further support the activation of proinflammatory NLRP3 inflammasome signaling due to mitochondrial dysfunction. Collectively, our results demonstrate that mitochondrial impairment in microglia can amplify NLRP3 inflammasome signaling, which augments the dopaminergic neurodegenerative process.
Dynamic changes in mitochondria support phenotypic flexibility of microglia

Katherine Espinoza,Ari W. Schaler,Daniel T. Gray,Arielle Sass,Kamilia Moore,Megan Yu,Casandra Chamorro,Lindsay M. De Biase

DOI: https://doi.org/10.1101/2024.05.18.594002

2024-10-04

Abstract:Microglial capacity to adapt to local tissue needs is a hallmark feature of these cells. Yet, a full understanding of the intracellular machinery that allows them to rapidly adjust their cellular phenotype is lacking. New studies show that macrophage ability to alter cellular phenotype is critically regulated by their mitochondria. Indeed, mitochondria are increasingly recognized as key intracellular signaling and regulatory hubs, in addition to their well-established role as ATP producers. Surprisingly little is known about microglial mitochondria in vivo and whether they play similar roles in regulating microglial capacity to alter cellular phenotype. Here, we generated novel transgenic crosses for accurate visualization of microglial mitochondria and found, unexpectedly, that mitochondria did not appear to regulate microglial tissue surveillance. However, brain regions where microglia show early responses to aging also showed early changes in microglial mitochondria. Microglial mitochondria were also altered within hours of LPS injections and microglial expression of inflammation-, trophic-, and phagocytosis-relevant genes was strongly correlated with expression levels of specific mitochondria-relevant genes. Finally, direct genetic manipulation of microglial mitochondria altered microglial morphology and led to brain-region specific effects on microglial gene expression. Overall, this study provides foundational information about microglial mitochondria and their relationship to differences in cell phenotype that occur across brain region, during pathological insults, and during aging.

Neuroscience

Microglia activation: a role for mitochondrial DNA?

Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia

Activation of Microglia Depends on Na+/H+Exchange-Mediated H+Homeostasis

Microglial Activation Induced by Neurodegeneration

Hidden role of microglia during neurodegenerative disorders and neurocritical care: A mitochondrial perspective

Mitochondrial complex I activity in microglia sustains neuroinflammation

Role of Mitochondrial Dynamics in Microglial Activation and Metabolic Switch

Mitochondrial DNA Leakage and cGas/STING Pathway in Microglia: Crosstalk Between Neuroinflammation and Neurodegeneration

Polymorphic regulation of mitochondrial fission and fusion modifies phenotypes of microglia in neuroinflammation

Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease

Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases

Microglial mitochondrial DNA release contributes to neuroinflammation after intracerebral hemorrhage through activating AIM2 inflammasome

Mitochondria in Neurogenesis: Implications for Mitochondrial Diseases

Cytoplasmic Escape of Mitochondrial DNA Mediated by Mfn2 Downregulation Promotes Microglial Activation Via Cgas‐sting Axis in Spinal Cord Injury (adv. Sci. 4/2024)

Mitochondrial reverse electron transport in myeloid cells perpetuates neuroinflammation

Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration

Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy

Miro1 Enhances Mitochondria Transfer from Multipotent Mesenchymal Stem Cells (MMSC) to Neural Cells and Improves the Efficacy of Cell Recovery

Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s disease

Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease

Dynamic changes in mitochondria support phenotypic flexibility of microglia